Follow The Filings

INSM Insmed

Insmed earnings company data as of 3:58 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by INSM's executives, directors and 10% owners in the last 12 months, from their Form 4s

All INSM insider trades
  • None no insider bought on the open market
  • $63.3M sold by 6 insiders outside a trading plan
  • $92M sold by 5 insiders under 10b5-1 plans
  1. David R Brennan Director
    Sale
    $3.1M 25,000 shares at $124.00 39% of stake
    Traded Sep 9 Filed Sep 11
    ↗
  2. Melvin Sharoky MD Director
    Sale
    $638K 5,000 shares at $127.53 100% of stake
    Traded Aug 17 Filed Aug 19
    ↗
  3. Roger Adsett COO
    Sale
    $32M 239,850 shares at $133.27 71% of stake
    Traded Aug 10 Filed Aug 12
    ↗
  4. Martina Flammer M.D. Chief Medical Officer
    Planned sale
    $3.5M 27,173 shares at $128.61 31% of stake
    Traded Aug 6 Filed Aug 7
    ↗
  5. William Lewis CEO
    Planned sale
    $1.1M 10,700 shares at $106.06 4% of stake
    Traded Jul 23 Filed Jul 24
    ↗
  6. William Lewis CEO
    Planned sale
    $1.3M 10,699 shares at $117.40 4% of stake
    Traded Jul 9 Filed Jul 10
    ↗
  7. Martina Flammer M.D. Chief Medical Officer
    Planned sale
    $1.4M 12,302 shares at $109.98 17% of stake
    Traded Jul 6 Filed Jul 8
    ↗
  8. William Lewis CEO
    Planned sale
    $2.2M 21,398 shares at $103.32 7.6% of stake
    Traded Jun 25 Filed Jun 26
    ↗
  9. Michael Alexander Smith Chief Legal Officer
    Planned sale
    $173K 1,806 shares at $95.82 4.6% of stake
    Traded Jun 22 Filed Jun 24
    ↗
  10. William Lewis CEO
    Planned sale
    $613K 6,515 shares at $94.03 2.5% of stake
    Traded Jun 8 Filed Jun 10
    ↗
  11. Martina Flammer M.D. Chief Medical Officer
    Planned sale
    $193K 1,858 shares at $103.78 3% of stake
    Traded Jun 5 Filed Jun 5
    ↗
  12. Michael Alexander Smith Chief Legal Officer
    Planned sale
    $667K 6,149 shares at $108.47 13% of stake
    Traded May 22 Filed May 22
    ↗
  13. William Lewis CEO
    Planned sale
    $2.7M 25,564 shares at $106.33 8.6% of stake
    Traded May 18 Filed May 20
    ↗
  14. Martina Flammer M.D. Chief Medical Officer
    Planned sale
    $1.2M 10,479 shares at $117.54 14% of stake
    Traded May 14 Filed May 15
    ↗
  15. Martina Flammer M.D. Chief Medical Officer
    Planned sale
    $1.3M 12,949 shares at $100.40 14% of stake
    Traded May 11 Filed May 13
    ↗

Also filed in the last 12 months, not counted as buying or selling: 52 option exercises, 31 sales to cover taxes, 17 stock grants, and 11 gifts.

SEC filings

Recent issuer filings from EDGAR, 9 shown.

Filed Form Detail Links
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 3 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.